Cargando…

Development and characterization of novel hydrogel containing antimicrobial drug for treatment of burns

INTRODUCTION: The aim of burn management and therapy is fast healing and epithelisation to prevent infection. The present study is concerned with the development and characterization of a novel nanaoparticulate system; cubosomes, loaded with silver sulfadiazine (SSD) and Aloe vera for topical treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Thakkar, Vaishali, Korat, Vaishali, Baldaniya, Lalji, Gohel, Mukesh, Gandhi, Tejal, Patel, Nirav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991124/
https://www.ncbi.nlm.nih.gov/pubmed/27606259
http://dx.doi.org/10.4103/2230-973X.187343
_version_ 1782448803739074560
author Thakkar, Vaishali
Korat, Vaishali
Baldaniya, Lalji
Gohel, Mukesh
Gandhi, Tejal
Patel, Nirav
author_facet Thakkar, Vaishali
Korat, Vaishali
Baldaniya, Lalji
Gohel, Mukesh
Gandhi, Tejal
Patel, Nirav
author_sort Thakkar, Vaishali
collection PubMed
description INTRODUCTION: The aim of burn management and therapy is fast healing and epithelisation to prevent infection. The present study is concerned with the development and characterization of a novel nanaoparticulate system; cubosomes, loaded with silver sulfadiazine (SSD) and Aloe vera for topical treatment of infected burns. METHODS: Cubosome dispersions were formulated by an emulsification technique using different concentrations of a lipid phase Glyceryl Monooleate (GMO) and Poloxamer 407. The optimum formulae were incorporated in an aloe vera gel containing carbopol 934, to form cubosomal hydrogels (cubogels). The cubogels were characterized by in vitro release of SSD, rheological properties, pH, bioadhesion, Transmission Electron Microscopy and in-vivo Wound Healing Study. RESULTS: The results show that the different concentration of GMO had significant effect on particle size, % EE and in vitro drug release. From the in-vitro drug release pattern and similarity factor (f(2)), it was concluded that batch CG3 (15% GMO and 1% P407) exhibited complete and controlled drug release within 12 hour (i.e. 98.25%), better bio adhesion and superior burn healing as compared to the marketed product. CONCLUSION: The in vivo burns healing study in rats revealed that the prepared optimized cubogel containing SSD and aloe vera has superior burns healing rate than cubogel with only SSD and marketed preparation so, it may be successfully used in the treatment of deep second degree burn.
format Online
Article
Text
id pubmed-4991124
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-49911242016-09-07 Development and characterization of novel hydrogel containing antimicrobial drug for treatment of burns Thakkar, Vaishali Korat, Vaishali Baldaniya, Lalji Gohel, Mukesh Gandhi, Tejal Patel, Nirav Int J Pharm Investig Original Research Article INTRODUCTION: The aim of burn management and therapy is fast healing and epithelisation to prevent infection. The present study is concerned with the development and characterization of a novel nanaoparticulate system; cubosomes, loaded with silver sulfadiazine (SSD) and Aloe vera for topical treatment of infected burns. METHODS: Cubosome dispersions were formulated by an emulsification technique using different concentrations of a lipid phase Glyceryl Monooleate (GMO) and Poloxamer 407. The optimum formulae were incorporated in an aloe vera gel containing carbopol 934, to form cubosomal hydrogels (cubogels). The cubogels were characterized by in vitro release of SSD, rheological properties, pH, bioadhesion, Transmission Electron Microscopy and in-vivo Wound Healing Study. RESULTS: The results show that the different concentration of GMO had significant effect on particle size, % EE and in vitro drug release. From the in-vitro drug release pattern and similarity factor (f(2)), it was concluded that batch CG3 (15% GMO and 1% P407) exhibited complete and controlled drug release within 12 hour (i.e. 98.25%), better bio adhesion and superior burn healing as compared to the marketed product. CONCLUSION: The in vivo burns healing study in rats revealed that the prepared optimized cubogel containing SSD and aloe vera has superior burns healing rate than cubogel with only SSD and marketed preparation so, it may be successfully used in the treatment of deep second degree burn. Medknow Publications & Media Pvt Ltd 2016 /pmc/articles/PMC4991124/ /pubmed/27606259 http://dx.doi.org/10.4103/2230-973X.187343 Text en Copyright: © International Journal of Pharmaceutical Investigation http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Research Article
Thakkar, Vaishali
Korat, Vaishali
Baldaniya, Lalji
Gohel, Mukesh
Gandhi, Tejal
Patel, Nirav
Development and characterization of novel hydrogel containing antimicrobial drug for treatment of burns
title Development and characterization of novel hydrogel containing antimicrobial drug for treatment of burns
title_full Development and characterization of novel hydrogel containing antimicrobial drug for treatment of burns
title_fullStr Development and characterization of novel hydrogel containing antimicrobial drug for treatment of burns
title_full_unstemmed Development and characterization of novel hydrogel containing antimicrobial drug for treatment of burns
title_short Development and characterization of novel hydrogel containing antimicrobial drug for treatment of burns
title_sort development and characterization of novel hydrogel containing antimicrobial drug for treatment of burns
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991124/
https://www.ncbi.nlm.nih.gov/pubmed/27606259
http://dx.doi.org/10.4103/2230-973X.187343
work_keys_str_mv AT thakkarvaishali developmentandcharacterizationofnovelhydrogelcontainingantimicrobialdrugfortreatmentofburns
AT koratvaishali developmentandcharacterizationofnovelhydrogelcontainingantimicrobialdrugfortreatmentofburns
AT baldaniyalalji developmentandcharacterizationofnovelhydrogelcontainingantimicrobialdrugfortreatmentofburns
AT gohelmukesh developmentandcharacterizationofnovelhydrogelcontainingantimicrobialdrugfortreatmentofburns
AT gandhitejal developmentandcharacterizationofnovelhydrogelcontainingantimicrobialdrugfortreatmentofburns
AT patelnirav developmentandcharacterizationofnovelhydrogelcontainingantimicrobialdrugfortreatmentofburns